Cooper H A, Clemetson K J, Lüscher E F
Proc Natl Acad Sci U S A. 1979 Mar;76(3):1069-73. doi: 10.1073/pnas.76.3.1069.
The platelet membrane receptor for bovine von Willebrand factor, platelet aggregating factor, has been reported to be a property of a soluble glycoprotein, glycocalicin, that is loosely attached to the platelet surface and represents one of the major glycoproteins of the platelet glycocalyx. The studies reported here, however, demonstrate that fractions from human platelets containing glycocalicin have no bovine von Willebrand factor receptor activity. Instead, only fractions containing platelet membranes have receptor activity. By using a nonionic detergent, Brij 99, active receptor can be solubilized from the membrane. Some quantitation of the intact or solubilized receptor activity is possible because the aggregation curves produced by mixtures of various dilutions of membranes and a constant concentration of standard normal bovine plasma are linear when plotted against the logarithm of the concentration of receptor. The dose-response curve obtained with Brij 99-solubilized membranes is not parallel to that obtained with intact membranes. Lectin-specificity studies of the bovine von Willebrand factor receptor, soluble in Brij 99, demonstrate binding to a wheat germ agglutinin-Sepharose 4B affinity gel but little or no binding to similar affinity gels of concanavalin A or Lens culinaris lectin. By using wheat germ agglutinin-Sepharose 4B as a lectin affinity column, partial purification of the receptor is possible. Stability studies of the receptor in intact membranes show essentially no loss of activity for at least 6 days when membranes are stored at 4 degrees C in buffers containing 1 mM EDTA. One freezing and thawing cycle results in minimal loss of initial activity but the receptor activity of the thawed material is less stable over time than is fresh material. Repeated freezing and thawing destroys the activity and, once lost, it can not be recovered, even with detergents.
据报道,牛血管性血友病因子的血小板膜受体——血小板聚集因子,是一种可溶性糖蛋白即糖萼蛋白的特性,该蛋白松散地附着于血小板表面,是血小板糖萼的主要糖蛋白之一。然而,本文报道的研究表明,来自人血小板的含有糖萼蛋白的组分没有牛血管性血友病因子受体活性。相反,只有含有血小板膜的组分具有受体活性。通过使用非离子去污剂Brij 99,可以从膜中溶解活性受体。由于当以受体浓度的对数作图时,由各种稀释度的膜与恒定浓度的标准正常牛血浆混合产生的聚集曲线是线性的,因此可以对完整或溶解的受体活性进行一些定量。用Brij 99溶解的膜获得的剂量反应曲线与用完整膜获得的曲线不平行。对可溶于Brij 99的牛血管性血友病因子受体进行的凝集素特异性研究表明,它能与麦胚凝集素-琼脂糖4B亲和凝胶结合,但与伴刀豆球蛋白A或扁豆凝集素的类似亲和凝胶几乎没有或没有结合。通过使用麦胚凝集素-琼脂糖4B作为凝集素亲和柱,可以对受体进行部分纯化。完整膜中受体的稳定性研究表明,当膜在含有1 mM EDTA的缓冲液中于4℃储存时,至少6天内活性基本没有损失。一次冻融循环导致初始活性的损失最小,但解冻材料的受体活性随时间的稳定性不如新鲜材料。反复冻融会破坏活性,一旦失去,即使使用去污剂也无法恢复。